← Research hub  ·  securities

PRA · ProAssurance

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK · FA2 mentions
2026-JUN-28 · Jay Singh · Weekly SSR research call (premium) · Neutralmention · source page ↗$25.00

In short: Arb closing: its sale to The Doctors Company got final approval and is set to close Friday — 16 grueling months after announcement, but still a ~7% IRR if set on day one.

Full passage: premium transcript (PDF).

SOD $25.00 (open 2026-JUN-26)
2026-JUN-07 · Jay Singh · Weekly SSR research call (premium) · Neutralinsight · source page ↗$24.53

In short: Merger-arb — management reiterated guidance to close by June 30, 2026 (incremental positive), but the name has been a laggard among the arb book.

In plain English

ProAssurance is a medical-malpractice insurance company that is in the process of being acquired. Management recently confirmed they still expect the deal to close by June 30, which is a small positive.

It's another merger-arbitrage position, but it has been a weak performer — one of the laggards in the basket of deal-driven bets — so the view is lukewarm.

Full passage: premium transcript (PDF).

SOD $24.53 (open 2026-JUN-05)

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.